Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

● According to Refinitiv, the company's ESG score for its industry is good.


Strengths

● Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 106% by 2024.

● The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.

● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.51 for the 2022 fiscal year.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

● The opinion of analysts covering the stock has improved over the past four months.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.


Weaknesses

● Low profitability weakens the company.

● The company is in debt and has limited leeway for investment

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 53.92 times its estimated earnings per share for the ongoing year.

● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.